{"count": 11, "results": [{"_id": "37638270", "pmid": 37638270, "pmcid": "PMC10449231", "title": "Silent Myocardial Infarction: A Case Report", "journal": "Cureus", "authors": ["Kolesova MV", "Minor S"], "date": "2023-08-22T00:00:00Z", "doi": "10.7759/cureus.43906", "meta_date_publication": "2023 Aug", "meta_volume": "15", "meta_issue": "8", "meta_pages": "e43906", "score": 50264.426, "text_hl": "Typically, @SPECIES_9606 @@@patients@@@ presenting with @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@MI@@@ may exhibit symptoms of @DISEASE_Chest_Pain @DISEASE_MESH:D002637 @@@chest pain@@@, squeezing chest pressure, and @<m>DISEASE_Dyspnea</m> @DISEASE_MESH:D004417 @@@shortness of breath@@@ (@<m>DISEASE_Dyspnea</m> @DISEASE_MESH:D004417 @@@SOB@@@) at rest or upon minimal exertion. ", "citations": {"NLM": "Kolesova MV, Minor S. Silent Myocardial Infarction: A Case Report Cureus. 2023 Aug;15(8):e43906. PMID: 37638270", "BibTeX": "@article{37638270, title={Silent Myocardial Infarction: A Case Report}, author={Kolesova MV and Minor S}, journal={Cureus}, volume={15}, number={8}, pages={e43906}}"}}, {"_id": "37701005", "pmid": 37701005, "pmcid": "PMC10493181", "title": "Worsening Hypothyroidism in the Setting of New-Onset Nephrotic Syndrome", "journal": "Cureus", "authors": ["Wang Q", "Ravi D", "Tang Z", "Nand N", "Dahhan A"], "date": "2023-08-11T00:00:00Z", "doi": "10.7759/cureus.43345", "meta_date_publication": "2023 Aug", "meta_volume": "15", "meta_issue": "8", "meta_pages": "e43345", "score": 50241.91, "text_hl": "Her symptoms gradually improved after receiving a higher dose of @CHEMICAL_Thyroxine @CHEMICAL_MESH:D013974 @@@levothyroxine@@@, along with diuretics and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ initiation. ", "citations": {"NLM": "Wang Q, Ravi D, Tang Z, Nand N, Dahhan A. Worsening Hypothyroidism in the Setting of New-Onset Nephrotic Syndrome Cureus. 2023 Aug;15(8):e43345. PMID: 37701005", "BibTeX": "@article{37701005, title={Worsening Hypothyroidism in the Setting of New-Onset Nephrotic Syndrome}, author={Wang Q and Ravi D and Tang Z and Nand N and Dahhan A}, journal={Cureus}, volume={15}, number={8}, pages={e43345}}"}}, {"_id": "7560247", "pmid": 7560247, "title": "Lisinopril versus placebo in the treatment of heart failure: the Lisinopril Heart Failure Study Group.", "journal": "J Clin Pharmacol", "authors": ["Beller B", "Bulle T", "Bourge RC", "Colfer H", "Fowles RE", "Giles TD", "Grover J", "Whipple JP", "Fisher MB", "Jessup M"], "date": "1995-07-01T00:00:00Z", "doi": "10.1002/j.1552-4604.1995.tb04107.x", "meta_date_publication": "1995 Jul", "meta_volume": "35", "meta_issue": "7", "meta_pages": "673-80", "score": 50072.676, "text_hl": "In @SPECIES_9606 @@@patients@@@ receiving @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, the increase in exercise duration was accompanied by an improvement in quality of life as measured by the Yale Scale @<m>DISEASE_Dyspnea</m> @DISEASE_MESH:D004417 @@@Dyspnea@@@/@DISEASE_Fatigue @DISEASE_MESH:D005221 @@@Fatigue@@@ Index and in signs and symptoms of @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@. ", "citations": {"NLM": "Beller B, Bulle T, Bourge RC, Colfer H, Fowles RE, Giles TD, Grover J, Whipple JP, Fisher MB, Jessup M. Lisinopril versus placebo in the treatment of heart failure: the Lisinopril Heart Failure Study Group. J Clin Pharmacol. 1995 Jul;35(7):673-80. PMID: 7560247", "BibTeX": "@article{7560247, title={Lisinopril versus placebo in the treatment of heart failure: the Lisinopril Heart Failure Study Group.}, author={Beller B and Bulle T and Bourge RC and Colfer H and Fowles RE and Giles TD and Grover J and Whipple JP and Fisher MB and Jessup M}, journal={J Clin Pharmacol}, volume={35}, number={7}, pages={673-80}}"}}, {"_id": "1965241", "pmid": 1965241, "title": "Severe hyponatremia: an association with lisinopril?", "journal": "DICP", "authors": ["Hume AL", "Jack BW", "Levinson P"], "date": "1990-12-01T00:00:00Z", "doi": "10.1177/106002809002401204", "meta_date_publication": "1990 Dec", "meta_volume": "24", "meta_issue": "12", "meta_pages": "1169-72", "score": 50068.934, "text_hl": "The @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ was discontinued on admission. ", "citations": {"NLM": "Hume AL, Jack BW, Levinson P. Severe hyponatremia: an association with lisinopril? DICP. 1990 Dec;24(12):1169-72. PMID: 1965241", "BibTeX": "@article{1965241, title={Severe hyponatremia: an association with lisinopril?}, author={Hume AL and Jack BW and Levinson P}, journal={DICP}, volume={24}, number={12}, pages={1169-72}}"}}, {"_id": "31395267", "pmid": 31395267, "title": "A Man in His 50s With Hemoptysis, Dyspnea, and Bilateral Patchy Ground-Glass Opacities.", "journal": "Chest", "authors": ["Edward JA", "Lee JS", "Moore PK", "Levy AK"], "date": "2019-08-01T00:00:00Z", "doi": "10.1016/j.chest.2019.03.021", "meta_date_publication": "2019 Aug", "meta_volume": "156", "meta_issue": "2", "meta_pages": "e41-e45", "score": 50065.367, "text_hl": "A Man in His 50s With @DISEASE_Hemoptysis @DISEASE_MESH:D006469 @@@Hemoptysis@@@, @<m>DISEASE_Dyspnea</m> @DISEASE_MESH:D004417 @@@Dyspnea@@@, and Bilateral Patchy Ground-Glass Opacities.", "citations": {"NLM": "Edward JA, Lee JS, Moore PK, Levy AK. A Man in His 50s With Hemoptysis, Dyspnea, and Bilateral Patchy Ground-Glass Opacities. Chest. 2019 Aug;156(2):e41-e45. PMID: 31395267", "BibTeX": "@article{31395267, title={A Man in His 50s With Hemoptysis, Dyspnea, and Bilateral Patchy Ground-Glass Opacities.}, author={Edward JA and Lee JS and Moore PK and Levy AK}, journal={Chest}, volume={156}, number={2}, pages={e41-e45}}"}}, {"_id": "2539403", "pmid": 2539403, "title": "Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group.", "journal": "J Am Coll Cardiol", "authors": ["Giles TD", "Katz R", "Sullivan JM", "Wolfson P", "Haugland M", "Kirlin P", "Powers E", "Rich S", "Hackshaw B", "Chiaramida A"], "date": "1989-05-01T00:00:00Z", "doi": "10.1016/0735-1097(89)90294-5", "meta_date_publication": "1989 May", "meta_volume": "13", "meta_issue": "6", "meta_pages": "1240-7", "score": 50055.75, "text_hl": "Improvement in functional capacity and quality of life, as assessed by the Yale Scale @<m>DISEASE_Dyspnea</m> @DISEASE_MESH:D004417 @@@dyspnea@@@/@DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@ index, was significantly greater for the @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ group.", "citations": {"NLM": "Giles TD, Katz R, Sullivan JM, Wolfson P, Haugland M, Kirlin P, Powers E, Rich S, Hackshaw B, Chiaramida A. Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group. J Am Coll Cardiol. 1989 May;13(6):1240-7. PMID: 2539403", "BibTeX": "@article{2539403, title={Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group.}, author={Giles TD and Katz R and Sullivan JM and Wolfson P and Haugland M and Kirlin P and Powers E and Rich S and Hackshaw B and Chiaramida A}, journal={J Am Coll Cardiol}, volume={13}, number={6}, pages={1240-7}}"}}, {"_id": "30395904", "pmid": 30395904, "title": "Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.", "journal": "Int J Radiat Oncol Biol Phys", "authors": ["Sio TT", "Atherton PJ", "Pederson LD", "Zhen WK", "Mutter RW", "Garces YI", "Ma DJ", "Leenstra JL", "Rwigema JM", "Dakhil S", "Bearden JD", "van der Veen SJ", "Ganti AK", "Schild SE", "Miller RC"], "date": "2019-03-01T00:00:00Z", "doi": "10.1016/j.ijrobp.2018.10.035", "meta_date_publication": "2019 Mar 1", "meta_volume": "103", "meta_issue": "3", "meta_pages": "686-696", "score": 50050.2, "text_hl": "Few PRO measures suggested that compared with the placebo arm, @SPECIES_9606 @@@patients@@@ receiving @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ had less @DISEASE_Cough @DISEASE_MESH:D003371 @@@cough@@@, less @<m>DISEASE_Dyspnea</m> @DISEASE_MESH:D004417 @@@shortness of breath@@@, fewer symptoms from @DISEASE_Lung_Neoplasms @DISEASE_MESH:D008175 @@@lung cancer@@@, less @<m>DISEASE_Dyspnea</m> @DISEASE_MESH:D004417 @@@dyspnea@@@ with both walking and climbing stairs, and better overall quality of life (for all, P < .05). ", "citations": {"NLM": "Sio TT, Atherton PJ, Pederson LD, Zhen WK, Mutter RW, Garces YI, Ma DJ, Leenstra JL, Rwigema JM, Dakhil S, Bearden JD, van der Veen SJ, Ganti AK, Schild SE, Miller RC. Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial. Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):686-696. PMID: 30395904", "BibTeX": "@article{30395904, title={Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.}, author={Sio TT and Atherton PJ and Pederson LD and Zhen WK and Mutter RW and Garces YI and Ma DJ and Leenstra JL and Rwigema JM and Dakhil S and Bearden JD and van der Veen SJ and Ganti AK and Schild SE and Miller RC}, journal={Int J Radiat Oncol Biol Phys}, volume={103}, number={3}, pages={686-696}}"}}, {"_id": "19829931", "pmid": 19829931, "pmcid": "PMC2740143", "title": "ACE-I induced angioedema: a case report and review of literature", "journal": "Cases J", "authors": ["Adebayo PB", "Alebiosu OC"], "date": "2009-07-27T00:00:00Z", "doi": "10.4076/1757-1626-2-7181", "meta_date_publication": "2009 Jul 27", "meta_volume": "2", "meta_issue": "", "meta_pages": "7181", "score": 50047.3, "text_hl": "...@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ was discontinued. ", "citations": {"NLM": "Adebayo PB, Alebiosu OC. ACE-I induced angioedema: a case report and review of literature Cases J. 2009 Jul 27;2():7181. PMID: 19829931", "BibTeX": "@article{19829931, title={ACE-I induced angioedema: a case report and review of literature}, author={Adebayo PB and Alebiosu OC}, journal={Cases J}, volume={2}, pages={7181}}"}}, {"_id": "8723397", "pmid": 8723397, "title": "Quality of life with ACE inhibitors in chronic heart failure.", "journal": "J Cardiovasc Pharmacol", "authors": ["Bulpitt CJ"], "date": "1996-01-01T00:00:00Z", "doi": "10.1097/00005344-199600002-00007", "meta_date_publication": "1996", "meta_volume": "27 Suppl 2", "meta_issue": "", "meta_pages": "S31-5", "score": 50044.434, "text_hl": "The Minnesota Living with @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@Heart Failure@@@ Questionnaire has demonstrated the benefits of @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ in some but not all circumstances and the Yale @<m>DISEASE_Dyspnea</m> @DISEASE_MESH:D004417 @@@Dyspnea@@@-@DISEASE_Fatigue @DISEASE_MESH:D005221 @@@Fatigue@@@ Index improves with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@. ", "citations": {"NLM": "Bulpitt CJ. Quality of life with ACE inhibitors in chronic heart failure. J Cardiovasc Pharmacol. 1996;27 Suppl 2():S31-5. PMID: 8723397", "BibTeX": "@article{8723397, title={Quality of life with ACE inhibitors in chronic heart failure.}, author={Bulpitt CJ}, journal={J Cardiovasc Pharmacol}, volume={27 Suppl 2}, pages={S31-5}}"}}, {"_id": "27278166", "pmid": 27278166, "title": "The efficacy of cibenzoline for reducing the left ventricular pressure gradient of hypertrophic obstructive cardiomyopathy: A case report.", "journal": "J Med Ultrason (2001)", "authors": ["Igarashi H"], "date": "2003-06-01T00:00:00Z", "doi": "10.1007/BF02481371", "meta_date_publication": "2003 Jun", "meta_volume": "30", "meta_issue": "2", "meta_pages": "111-4", "score": 50042.234, "text_hl": "A 46 year-old man with @DISEASE_Cardiomyopathy_Hypertrophic @DISEASE_MESH:D002312 @@@hypertrophic obstructive cardiomyopathy@@@ (@DISEASE_Cardiomyopathy_Hypertrophic @DISEASE_MESH:D002312 @@@HOCM@@@) was referred to this clinic complaining of @<m>DISEASE_Dyspnea</m> @DISEASE_MESH:D004417 @@@shortness of breath@@@. His symptoms remained even after he had been treated with @CHEMICAL_Bisoprolol @CHEMICAL_MESH:D017298 @@@bisoprolol@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, and @CHEMICAL_Verapamil @CHEMICAL_MESH:D014700 @@@verapamil@@@. ", "citations": {"NLM": "Igarashi H. The efficacy of cibenzoline for reducing the left ventricular pressure gradient of hypertrophic obstructive cardiomyopathy: A case report. J Med Ultrason (2001). 2003 Jun;30(2):111-4. PMID: 27278166", "BibTeX": "@article{27278166, title={The efficacy of cibenzoline for reducing the left ventricular pressure gradient of hypertrophic obstructive cardiomyopathy: A case report.}, author={Igarashi H}, journal={J Med Ultrason (2001)}, volume={30}, number={2}, pages={111-4}}"}}]}